Here's Why Shares in Danaher Got Boosted Higher Today

Shares in biotechnology, life sciences, and diagnostics company Danaher (NYSE: DHR) rose by as much as 12.9% in early morning trading today. The move follows a well-received third-quarter earnings report, which saw the company beat its own and the market's expectations.Having forecast core revenue growth in the low-single-digit range and an adjusted operating profit margin of 25.5% for the third quarter on its second-quarter earnings call, management was pleased to announce core revenue growth of 3% and an adjusted operating profit margin of 27.9% for the third quarter. Management put the outperformance down to "DBS-driven execution paired with continued momentum in our bioprocessing business and better-than-anticipated respiratory revenue at Cepheid." DBS refers to the Danaher Business System (a management system emphasizing continuous improvement). Danaher's bioprocessing business continues on a strong growth path, driven by increasing production and research into biologics, notably monoclonal antibodies. Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool